Regulation - Roche

Filter

Current filters:

Roche

Popular Filters

126 to 134 of 134 results

US FDA revokes Roche/Genentech Avastin license for metastatic breast cancer

21-11-2011

After months of deliberations, the US Food and Drug Administration (FDA Commissioner is revoking the…

AvastinBiotechnologyGenentechNorth AmericaOncologyPharmaceuticalRegulationRoche

FDA priority review for Roche/Genentech’s vismodegib for skin cancer

10-11-2011

The US Food and Drug Administration has accepted and filed Swiss drug major Roche (ROG: SIX) subsidiary…

BiotechnologyCurisGenentechNorth AmericaOncologyPharmaceuticalRegulationRochevismodegib

UK’s NICE provisionally backs wider use of Roche’s RoActemra for rheumatoid arthritis

07-10-2011

The drugs watchdog the National Institute for Health and Clinical Excellence (NICE) has today opened…

Anti-Arthritics/RheumaticsPharmaceuticalPricingRegulationRoActemraRoche

Genentech files with US FDA for vismodegib in rare form of advanced skin cancer

13-09-2011

In a second filing for a novel skin cancer drug this year, Swiss drug major Roche (ROG: SIX) US subsidiary…

BiotechnologyCurisGenentechNorth AmericaOncologyPharmaceuticalRegulationRochevismodegib

Two US FDA advisory panels say osteoporosis drugs need label changes

12-09-2011

Experts advising the US Food and Drug Administration have recommended revised labeling for bisphosphonates,…

ActonelAnti-Arthritics/RheumaticsBonvivaFosamaxMerck & CoNorth AmericaPharmaceuticalReclastRegulationRocheWarner Chilcott

Roche’s Tarceva Oked in EU for first-line use in a genetically distinct type of lung cancer

02-09-2011

Swiss drug major Roche (ROG: SIX) says that the European Commission has approved Tarceva (erlotinib)…

EuropeOncologyPharmaceuticalRegulationRocheTarceva

126 to 134 of 134 results

Company Spotlight

ImmunoGen

ImmunoGen

Back to top